{
  "originUrl": "https://www.fresenius-kabi.com",
  "aborted": false,
  "lastCrawled": "https://www.fresenius-kabi.com/",
  "urls": [
    {
      "url": "https://www.fresenius-kabi.com/",
      "source": "SITEMAPS",
      "targetPath": "/",
      "id": "a6ef1c412a6a474f4e09a2b645743828b6498d50"
    },
    {
      "url": "https://www.fresenius-kabi.com/company",
      "source": "SITEMAPS",
      "targetPath": "/company",
      "id": "09ddc875b30c56f99b07309aef4892d56b545e7d"
    },
    {
      "url": "https://www.fresenius-kabi.com/company/about-us",
      "source": "SITEMAPS",
      "targetPath": "/company/about-us",
      "id": "ef7e05a2a8d879746deab88519a0d733140c2ca8"
    },
    {
      "url": "https://www.fresenius-kabi.com/company/executive-leadership-team",
      "source": "SITEMAPS",
      "targetPath": "/company/executive-leadership-team",
      "id": "52d816974326d28a34801b7d2378c15447184dbf"
    },
    {
      "url": "https://www.fresenius-kabi.com/company/heritage",
      "source": "SITEMAPS",
      "targetPath": "/company/heritage",
      "id": "31fe67b45e29edd0a745dc3572fdbe7c0d926815"
    },
    {
      "url": "https://www.fresenius-kabi.com/company/quality-commitment",
      "source": "SITEMAPS",
      "targetPath": "/company/quality-commitment",
      "id": "4831a2b4c8e5d872d1d7f5db3e27820e65b8da1d"
    },
    {
      "url": "https://www.fresenius-kabi.com/company/vision",
      "source": "SITEMAPS",
      "targetPath": "/company/vision",
      "id": "80b37fef919a40b63495ca8696795da4ad2ff39a"
    },
    {
      "url": "https://www.fresenius-kabi.com/company/we-are-global",
      "source": "SITEMAPS",
      "targetPath": "/company/we-are-global",
      "id": "0ae98771c6c9ff9ec46e56aef0306f4c95f22a35"
    },
    {
      "url": "https://www.fresenius-kabi.com/news",
      "source": "SITEMAPS",
      "targetPath": "/news",
      "id": "52ca4298551c201f8d0e6f15e2f34ba741897891"
    },
    {
      "url": "https://www.fresenius-kabi.com/news-room",
      "source": "SITEMAPS",
      "targetPath": "/news-room",
      "id": "d14fe0b45264953d99d0a3cca594cc1344f39c63"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/20230802-press-release-fse-q2-23",
      "source": "SITEMAPS",
      "targetPath": "/news/20230802-press-release-fse-q2-23",
      "id": "dbb08d7a8d7b22ff681ced55b8a6b3cc86acf514"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/annual-report-2021-and-new-guidelines-for-fresenius",
      "source": "SITEMAPS",
      "targetPath": "/news/annual-report-2021-and-new-guidelines-for-fresenius",
      "id": "d782f57013e1969f6243aebb3c0e0fb5c69bd841"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/biosimilar-candidate-tocilizumab-accepted-for-review-by-fda",
      "source": "SITEMAPS",
      "targetPath": "/news/biosimilar-candidate-tocilizumab-accepted-for-review-by-fda",
      "id": "e00321e28ce83ec93527c7fc63a46e1c9b43bc77"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/business-report-first-quarter-2022-of-fresenius",
      "source": "SITEMAPS",
      "targetPath": "/news/business-report-first-quarter-2022-of-fresenius",
      "id": "ff56a2e50d3a5bb4feb0aaf1274cff2669ff43c7"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/business-report-second-quarter-and-first-half-of-2022",
      "source": "SITEMAPS",
      "targetPath": "/news/business-report-second-quarter-and-first-half-of-2022",
      "id": "375829a4ae5343a85d09fc74576b213cb1ed2749"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/business-report-third-quarter-of-2022-of-fresenius",
      "source": "SITEMAPS",
      "targetPath": "/news/business-report-third-quarter-of-2022-of-fresenius",
      "id": "5bf7278562e2aaa5a07896cd09e833b7ccf24545"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/european-commission-approval-tyenne-tocilizumab-biosimilar",
      "source": "SITEMAPS",
      "targetPath": "/news/european-commission-approval-tyenne-tocilizumab-biosimilar",
      "id": "62bed378217037dbd27a354ef46256fef0a3912a"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/europn-study-new-clinical-data-on-medical-nutrition-therapy",
      "source": "SITEMAPS",
      "targetPath": "/news/europn-study-new-clinical-data-on-medical-nutrition-therapy",
      "id": "3bff1c7d35ffcdcea737581b801592f334b4f1f0"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fda-submission-acceptance-ustekinumab-biosimilar",
      "source": "SITEMAPS",
      "targetPath": "/news/fda-submission-acceptance-ustekinumab-biosimilar",
      "id": "0f7f12723c78a650c6bb5bb0fbdd8b34f77a56b7"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-closes-2023-with-strong-fourth-quarter",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-closes-2023-with-strong-fourth-quarter",
      "id": "fc1eb8e23219cfe58176722dd6e04e444f77111f"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-commits-to-support-earthquake-victims-in-turkiye-and-syria",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-commits-to-support-earthquake-victims-in-turkiye-and-syria",
      "id": "0da13d0280cae08c6c06dd90cb4dd79d8520981a"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-and-esicm-continue-collaboration",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-and-esicm-continue-collaboration",
      "id": "67712a725833aece6c8835fec5e378731b3686ee"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-and-lupagen-enter-into-strategic-agreement",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-and-lupagen-enter-into-strategic-agreement",
      "id": "c867180da9b6a3b36da948b09cf1d4f851c64373"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-at-the-euroanaesthesia-2023",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-at-the-euroanaesthesia-2023",
      "id": "8ddd643464c9186f88701077fa236e2b1dc31637"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-awarded-technology-breakthrough-agreement-with-premier-inc",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-awarded-technology-breakthrough-agreement-with-premier-inc",
      "id": "d02c4194c2b8b795d4ccf6eb24fc16352bcad752"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-buys-a-majority-stake-in-mabxience-and-acquires",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-buys-a-majority-stake-in-mabxience-and-acquires",
      "id": "0f6953e3564aad59a95b00f45104d2973956b8f9"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-completes-acquisition-of-ivenix-inc",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-completes-acquisition-of-ivenix-inc",
      "id": "ea760e4a60a4ae6400cd80f4717db8caa0d2e35b"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-completes-majority-stake-acquisition-of-mabxience",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-completes-majority-stake-acquisition-of-mabxience",
      "id": "4da1454873e7449edab044ec9eb01d0127a85d3c"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-employees-team-up-for-breast-cancer-awareness",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-employees-team-up-for-breast-cancer-awareness",
      "id": "d010c932009c3b93f842912ec32bdf2c7f8da23b"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-establishes-partnership-with-fiocruz-bio-manguinhos-bionovis",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-establishes-partnership-with-fiocruz-bio-manguinhos-bionovis",
      "id": "b4df3741f1eaf1b0ad135a74f03782c2043f03e6"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-fiscal-year-2022-results-press-release",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-fiscal-year-2022-results-press-release",
      "id": "75d61f95bf9f496b634e66b79709d5894f2dfa93"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-formycon-license-date-ustekinumab-biosimilar",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-formycon-license-date-ustekinumab-biosimilar",
      "id": "93459e04a8d9fa2805df4c31b1771b0d6490bc96"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-inaugurates-extension-of-production-facilities-in-dominican-republic",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-inaugurates-extension-of-production-facilities-in-dominican-republic",
      "id": "6fcc787effa8a65e0dc3b4b5b1318e631ec45be1"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-launches-biosimilar-stimufend-in-the-us",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-launches-biosimilar-stimufend-in-the-us",
      "id": "8953cbe34c72db3e5581f9fe124fd1adbb65b3b3"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-launches-its-citrate-free-biosimilar-idacio",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-launches-its-citrate-free-biosimilar-idacio",
      "id": "62da8a859097ade948e175149e84f71654ad664d"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-launches-single-needle-option-for-amicus-extracorporeal-photopheresis",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-launches-single-needle-option-for-amicus-extracorporeal-photopheresis",
      "id": "ee573ea8552eebbdb2283ade306e2f07271da069"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-launches-tyenne-tocilizumab-biosimilar-eu",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-launches-tyenne-tocilizumab-biosimilar-eu",
      "id": "2143f3b6112c57c16d684f90550df2efeb19d374"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-mayo-clinic-ivenix-agreement",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-mayo-clinic-ivenix-agreement",
      "id": "52295ae87478099bf7e184576407ce52e172cc54"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-offers-100-000-grant-to-advance-nutritional",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-offers-100-000-grant-to-advance-nutritional",
      "id": "71b0efb38298f1e89c7fb3f2788c0d0b574ce100"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-prolongs-production-and-supply-contract-with-cerus",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-prolongs-production-and-supply-contract-with-cerus",
      "id": "77e137a0fd7936668c76eca94bad1f36dbf0d06d"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-provides-humanitarian-aid-for-ukraine",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-provides-humanitarian-aid-for-ukraine",
      "id": "634e97b58fa33ec592cb12e5a7a8f4858ca3a18c"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-receives-ec-approval-for-pegfilgrastim-biosimilar-stimufend",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-receives-ec-approval-for-pegfilgrastim-biosimilar-stimufend",
      "id": "c9db36d4a55375bc2b8b107ea88f253d8858322f"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-receives-fda-approval-for-biosimilar-idacio",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-receives-fda-approval-for-biosimilar-idacio",
      "id": "211cf3cac709de37021579efef68b2d2206cc103"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-receives-us-fda-approval-for-biosimilar",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-receives-us-fda-approval-for-biosimilar",
      "id": "e66575fc86c241d784a4a06febb0a82c771113e5"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-recognized-as-a-top-employer-in-2023",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-recognized-as-a-top-employer-in-2023",
      "id": "b23081a7b8896e670a49bc6dcdf467d6b4e8f32b"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-s-denosumab-biosimilar-candidate-fks518",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-s-denosumab-biosimilar-candidate-fks518",
      "id": "24444b102b42fa2d760f64402faceb95592d003c"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-tocilizumab-biosimilar-candidate-msb11456",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-tocilizumab-biosimilar-candidate-msb11456",
      "id": "ba0d929f97f900eb03ce0bd89fe0b31365511faa"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-kabi-tocilizumab-mma-accepted-by-ema",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-kabi-tocilizumab-mma-accepted-by-ema",
      "id": "a8ee0974511c6216f024470e0cc4b55333bf7ca6"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/fresenius-se-hosts-kabi-capital-markets-day",
      "source": "SITEMAPS",
      "targetPath": "/news/fresenius-se-hosts-kabi-capital-markets-day",
      "id": "cede51a9f0f952380c57dd1a1f35d0dda7eae475"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/further-donations-support-emergency-care-of-patients-ukraine",
      "source": "SITEMAPS",
      "targetPath": "/news/further-donations-support-emergency-care-of-patients-ukraine",
      "id": "15f44161bc2a9c5e2956d73a0c79361494bb990e"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/gastrointestinal-dysfunction-study-wins-esicm-clinical-nutrition-award",
      "source": "SITEMAPS",
      "targetPath": "/news/gastrointestinal-dysfunction-study-wins-esicm-clinical-nutrition-award",
      "id": "8a2cabc9a977dab34f8aca5d3d32549caff4d139"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/global-license-agreement-fresenius-kabi-and-formycon-to-commercialize-ustekinumab-biosimilar",
      "source": "SITEMAPS",
      "targetPath": "/news/global-license-agreement-fresenius-kabi-and-formycon-to-commercialize-ustekinumab-biosimilar",
      "id": "4ac51bc9455e457b0cc2ec9903ae66e5089f9225"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/help-for-communities-in-crisis",
      "source": "SITEMAPS",
      "targetPath": "/news/help-for-communities-in-crisis",
      "id": "8877e028abab731cd2c3c371bc3d7f74301aad6b"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/heroes-who-save-lives-thank-you-to-all-blood-and-plasma-donors",
      "source": "SITEMAPS",
      "targetPath": "/news/heroes-who-save-lives-thank-you-to-all-blood-and-plasma-donors",
      "id": "091bbab3ef4e847971032b3d01930b714791f195"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/international-day-of-women-in-science-interview-with-jumpstart-winner",
      "source": "SITEMAPS",
      "targetPath": "/news/international-day-of-women-in-science-interview-with-jumpstart-winner",
      "id": "0b82a1589672d39ca8b5a2c4e8cd5c89db73a064"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/ivenix-infusion-system-is-recognized-by-klas-research",
      "source": "SITEMAPS",
      "targetPath": "/news/ivenix-infusion-system-is-recognized-by-klas-research",
      "id": "ad295edb9e3b4e493e3f0fa249f0784a39670144"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/jumpstart-2022-driving-research-in-clinical-nutrition",
      "source": "SITEMAPS",
      "targetPath": "/news/jumpstart-2022-driving-research-in-clinical-nutrition",
      "id": "05e52e9a3cbaf7adac0da6c84793222b279991cb"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/jumpstart-clinical-nutrition-alumni-program",
      "source": "SITEMAPS",
      "targetPath": "/news/jumpstart-clinical-nutrition-alumni-program",
      "id": "88196272725a419172a286f1a24590ba7c03254c"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/jumpstart-clinical-nutrition-award-winner",
      "source": "SITEMAPS",
      "targetPath": "/news/jumpstart-clinical-nutrition-award-winner",
      "id": "99b0636e1005e3e5ab7a2c8ae9ff2d8789b05b5e"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/learning-and-creativity-for-little-patients",
      "source": "SITEMAPS",
      "targetPath": "/news/learning-and-creativity-for-little-patients",
      "id": "c34742889a5994f6624d70cb0463b57e4fd3e158"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/michael-sen-succeeds-former-fresenius-ceo-stephan-sturm",
      "source": "SITEMAPS",
      "targetPath": "/news/michael-sen-succeeds-former-fresenius-ceo-stephan-sturm",
      "id": "7187ba63b853667de7e4a1098a88e92f5536c9e3"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/new-appointments-to-the-management-board-at-fresenius",
      "source": "SITEMAPS",
      "targetPath": "/news/new-appointments-to-the-management-board-at-fresenius",
      "id": "c8cc56ebcdbdec8e90bf77aa20ca79129e724078"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/orf-film-plant-fresenius-kabi-austria",
      "source": "SITEMAPS",
      "targetPath": "/news/orf-film-plant-fresenius-kabi-austria",
      "id": "8c5fcfc7f81d7b9d2cdb83ca24a21f28d409c7ea"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/our-commitment-to-fight-antimicrobial-resistance",
      "source": "SITEMAPS",
      "targetPath": "/news/our-commitment-to-fight-antimicrobial-resistance",
      "id": "4916527f7c607b98fdcfef1a8e666ddf409b0dad"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/paving-the-way-for-the-future-of-blood-transfusions",
      "source": "SITEMAPS",
      "targetPath": "/news/paving-the-way-for-the-future-of-blood-transfusions",
      "id": "6634ea37de3f608abc6d9b71589986ba0f0a11ba"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/press-release-fse-q3-2023",
      "source": "SITEMAPS",
      "targetPath": "/news/press-release-fse-q3-2023",
      "id": "dd7470b7bf7a3748240df07ba71009833155a219"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/revision-of-group-guidance-for-2022-by-fresenius",
      "source": "SITEMAPS",
      "targetPath": "/news/revision-of-group-guidance-for-2022-by-fresenius",
      "id": "a19736999b7b5b79385acdd0fd4f3d8e9fd5655e"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/strong-development-of-the-operating-companies-in-q1-23",
      "source": "SITEMAPS",
      "targetPath": "/news/strong-development-of-the-operating-companies-in-q1-23",
      "id": "260b7047ec4bce643ffe21a47a2e2e522f3170c8"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/supporting-conscious-choices-in-nutritional-care",
      "source": "SITEMAPS",
      "targetPath": "/news/supporting-conscious-choices-in-nutritional-care",
      "id": "681895aa9a3f2dabd195d07064d080c8c6176691"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/ten-years-of-blood-donation-activity-across-china",
      "source": "SITEMAPS",
      "targetPath": "/news/ten-years-of-blood-donation-activity-across-china",
      "id": "ccf814f0202a3be7bf8efa4cbdb1f0c2561f864c"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/the-gift-of-life-a-decision-to-donate-blood-or-plasma",
      "source": "SITEMAPS",
      "targetPath": "/news/the-gift-of-life-a-decision-to-donate-blood-or-plasma",
      "id": "0422b2239ae923d12d469e12dc28a4ad791efe6b"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/top-employer-in-nine-countries",
      "source": "SITEMAPS",
      "targetPath": "/news/top-employer-in-nine-countries",
      "id": "7f4921673acb6db296ba687a48292b51c66d4a20"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/update-on-humanitarian-aid-for-ukraine",
      "source": "SITEMAPS",
      "targetPath": "/news/update-on-humanitarian-aid-for-ukraine",
      "id": "5b665a47ad5d4ddf9d0347374157aaea195abb2b"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/ustekinumab-biosimilar-ema-submission-acceptance",
      "source": "SITEMAPS",
      "targetPath": "/news/ustekinumab-biosimilar-ema-submission-acceptance",
      "id": "854b87e6008dce08b115a5df6b055a093109e3ff"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/virginia-oncology-associates-chooses-the-ivenix-infusion-system",
      "source": "SITEMAPS",
      "targetPath": "/news/virginia-oncology-associates-chooses-the-ivenix-infusion-system",
      "id": "b36659c7cb34262f338889653b12c2cc13219284"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/vision-2026-fresenius-kabi-healthy-growth-journey",
      "source": "SITEMAPS",
      "targetPath": "/news/vision-2026-fresenius-kabi-healthy-growth-journey",
      "id": "ba48a6a8229e4f206efc9f37b08d85ae4ce9328e"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/vizient-innovative-technology-contract-awarded-fresenius-kabi",
      "source": "SITEMAPS",
      "targetPath": "/news/vizient-innovative-technology-contract-awarded-fresenius-kabi",
      "id": "978e5aad2c187da137c4935e140a42cca5790348"
    },
    {
      "url": "https://www.fresenius-kabi.com/news/waterproof-zip-toiletry-bag-wins-queen-silvia-nursing-award",
      "source": "SITEMAPS",
      "targetPath": "/news/waterproof-zip-toiletry-bag-wins-queen-silvia-nursing-award",
      "id": "a8aa3383c992dbc0ab0123d8f8011d59bd942ad8"
    },
    {
      "url": "https://www.fresenius-kabi.com/portfolio",
      "source": "SITEMAPS",
      "targetPath": "/portfolio",
      "id": "41fa8e5b2448aeca158523fc66557eb5f8b68e48"
    },
    {
      "url": "https://www.fresenius-kabi.com/portfolio/biopharma",
      "source": "SITEMAPS",
      "targetPath": "/portfolio/biopharma",
      "id": "2b5092f0d0b0ae38122bb486dc3eeaa7367c5729"
    },
    {
      "url": "https://www.fresenius-kabi.com/portfolio/medtech",
      "source": "SITEMAPS",
      "targetPath": "/portfolio/medtech",
      "id": "e5e845869c43062bfa57baafe19c04696020a79b"
    },
    {
      "url": "https://www.fresenius-kabi.com/portfolio/medtech/dmea-congress",
      "source": "SITEMAPS",
      "targetPath": "/portfolio/medtech/dmea-congress",
      "id": "51722e4ac66c3bca93e1eda7d2a010eb4fdddaac"
    },
    {
      "url": "https://www.fresenius-kabi.com/portfolio/medtech/ebmt-congress",
      "source": "SITEMAPS",
      "targetPath": "/portfolio/medtech/ebmt-congress",
      "id": "05b220f10521ff89b50027174bf7b5fb23a53ba2"
    },
    {
      "url": "https://www.fresenius-kabi.com/portfolio/medtech/electronic-instructions-for-use-devices",
      "source": "SITEMAPS",
      "targetPath": "/portfolio/medtech/electronic-instructions-for-use-devices",
      "id": "8af84c34a6f71a840d8286ea9715a89cb9bdc71d"
    },
    {
      "url": "https://www.fresenius-kabi.com/portfolio/medtech/esge-days",
      "source": "SITEMAPS",
      "targetPath": "/portfolio/medtech/esge-days",
      "id": "20eb465f9e05dcf396822fb23f667cd48a42b8cd"
    },
    {
      "url": "https://www.fresenius-kabi.com/portfolio/medtech/isbt-congress",
      "source": "SITEMAPS",
      "targetPath": "/portfolio/medtech/isbt-congress",
      "id": "c2933dc771e3c4bfa375f4f0cde84b205f010d0a"
    },
    {
      "url": "https://www.fresenius-kabi.com/portfolio/nutrition",
      "source": "SITEMAPS",
      "targetPath": "/portfolio/nutrition",
      "id": "c51d083baf473d65901fe1027fedb6bc04f5c81d"
    },
    {
      "url": "https://www.fresenius-kabi.com/portfolio/nutrition/chronic-kidney-disease",
      "source": "SITEMAPS",
      "targetPath": "/portfolio/nutrition/chronic-kidney-disease",
      "id": "d08eae58bcda17ec4bef52584fa65f3ad9aff6af"
    },
    {
      "url": "https://www.fresenius-kabi.com/portfolio/nutrition/espen-congress",
      "source": "SITEMAPS",
      "targetPath": "/portfolio/nutrition/espen-congress",
      "id": "2f8321c26507234c366e74f2ff2140e94fde5d9b"
    },
    {
      "url": "https://www.fresenius-kabi.com/portfolio/nutrition/global-nutrition-webinar",
      "source": "SITEMAPS",
      "targetPath": "/portfolio/nutrition/global-nutrition-webinar",
      "id": "36c7f79e86cdff57e8408c368e418d30dfa38b28"
    },
    {
      "url": "https://www.fresenius-kabi.com/portfolio/pharma",
      "source": "SITEMAPS",
      "targetPath": "/portfolio/pharma",
      "id": "d01724ac5334c27048f847f60b39407e27b315cb"
    },
    {
      "url": "https://www.fresenius-kabi.com/sustainability",
      "source": "SITEMAPS",
      "targetPath": "/sustainability",
      "id": "92c7f21fa3ee2ece686799646707e75e0d072f4c"
    },
    {
      "url": "https://www.fresenius-kabi.com/sustainability/business-ethics",
      "source": "SITEMAPS",
      "targetPath": "/sustainability/business-ethics",
      "id": "591cb9646746f9ba524bbd450ae446a4a3b3f4c0"
    },
    {
      "url": "https://www.fresenius-kabi.com/sustainability/community",
      "source": "SITEMAPS",
      "targetPath": "/sustainability/community",
      "id": "434dc1ee235bfe33c4e5d697149d8221dcf8cbdc"
    },
    {
      "url": "https://www.fresenius-kabi.com/sustainability/employees",
      "source": "SITEMAPS",
      "targetPath": "/sustainability/employees",
      "id": "434a612ee054b9e1430aaf4f62f9319d605e0d92"
    },
    {
      "url": "https://www.fresenius-kabi.com/sustainability/environment",
      "source": "SITEMAPS",
      "targetPath": "/sustainability/environment",
      "id": "610cae428dc54741d5e925d222ce5f5b5ac8c2e9"
    },
    {
      "url": "https://www.fresenius-kabi.com/sustainability/quality-management",
      "source": "SITEMAPS",
      "targetPath": "/sustainability/quality-management",
      "id": "c980ae664fb200f1cf88ca058d83036a58f5ce98"
    },
    {
      "url": "https://www.fresenius-kabi.com/work-with-us",
      "source": "SITEMAPS",
      "targetPath": "/work-with-us",
      "id": "3e26c7017944e21c14d4fb6e7e50b5ab12b79e47"
    },
    {
      "url": "https://www.fresenius-kabi.com/work-with-us/why-us",
      "source": "SITEMAPS",
      "targetPath": "/work-with-us/why-us",
      "id": "ec3e22969b546e7fdd6c8dd09aaec8e53a3f2e12"
    },
    {
      "url": "https://www.fresenius-kabi.com/work-with-us/your-opportunities",
      "source": "SITEMAPS",
      "targetPath": "/work-with-us/your-opportunities",
      "id": "80bd4555e57f1e0b281e124d6fc537d6796cc3bb"
    }
  ],
  "crawlOptions": {
    "timeout": 64800000,
    "inclusionPatterns": [],
    "exclusionPatterns": [],
    "limit": 100,
    "sameDomain": true,
    "keepHash": false,
    "strategy": "sitemaps",
    "logger": {},
    "strategiesAttempted": [
      "SITEMAPS"
    ]
  },
  "extractionErrors": [],
  "errorCountMessage": "none",
  "error": null
}